Saturday 17 October 2026
Export IVA’s income statement to Excel — free account
Inventiva S.A. Sponsored ADR
Inventiva S.A. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $9.0 million, down 43.7% from fiscal 2024.
2.94
0.17
−5.47%
Follow IVA
| Jun '26 | Jun '25 | Jun '24 | Jun '23 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | 0.00 |
+8 more quarters Free account |
P/S ratio |
— | — | — | 10.73 | |
P/FCF ratio |
— | — | — | 0.00 | |
P/Operating CF |
— | — | — | (4.27) | |
P/B ratio |
— | — | — | 0.00 | |
Price to Tangible BV |
— | — | — | 0.00 | |
EV/Sales |
— | — | — | 10.94 | |
EV/EBITDA |
— | — | — | 0.00 | |
EV/Operating CF |
— | — | — | (1.68) | |
EV/FCF |
— | — | — | (1.67) | |
Quick Ratio |
2.68 | 2.29 | 0.28 | 1.00 | |
Current Ratio |
3.81 | 2.96 | 0.59 | 1.39 | |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
26.54% | 31.93% | 133.34% | 49.61% | |
Debt/Equity |
1.13 | (6.41) | (0.66) | (4.58) | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.18 | |
Operating CF/Net income |
— | 0.00 | 0.00 | 0.82 | |
Capex/Depreciation |
— | (0.01) | (0.09) | 0.00 | |
Interest Coverage |
— | — | — | 0.00 | |
Research and Development Expense of Revenue |
— | — | — | 2,788.06% | |
Selling, General and Administrative Expense of Revenue |
— | — | — | 389.95% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
— | — | — | (0.14) | |
Graham Number |
— | — | — | 3.59 | |
Earnings Yield |
— | — | — | (88.19%) | |
Free Cash Flow Yield |
— | — | — | (61.12%) | |
Revenue per Share |
— | — | — | 0.04 | |
Operating CF per Share |
— | 0.00 | 0.00 | (0.95) | |
Capex per Share |
— | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
— | 0.00 | 0.00 | 0.00 | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
— | (61.05) | (52.24) | (0.11) | |
Working Capital |
210.89 | 129.81 | (21.04) | 15.89 | |
Capital Expenditures |
— | (0.06) | (0.18) | (0.11) | |
Net Current Asset Value |
62.50 | (17.09) | (96.79) | (28.48) | |
EV/EBIT |
— | — | — | 0.00 | |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
— | — | — | 0.00 | |
| Other line items | |||||
Average Receivables |
8.93 | 10.19 | 8.48 | 5.38 | |
Average Payables |
30.37 | 27.12 | 27.99 | 21.78 | |
Average Inventory |
— | — | 0.41 | 0.48 | |
Average Assets |
207.60 | 157.86 | 90.11 | 109.23 | |
Average Common Equity |
58.34 | 31.09 | 7.49 | 49.15 |
Columns are period end dates · fundamentals updated 30 Sep 2026